Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.56 |
| ▸ | PPARA | Q07869 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3246059 | 0.98 | LMNA (0.65) | LMNAALOX15SMN1; SMN2ALDH1A1FFAR1 | |
| SCHEMBL27906819 | 0.98 | LMNA (0.65) | LMNAALOX15SMN1; SMN2ALDH1A1FFAR1 | |
| SCHEMBL10428800 | 0.91 | LMNA (0.58) | LMNAALOX15SMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL7260444 | 0.89 | MAPT (0.75) | LMNAALOX15SMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL9631701 | 0.89 | LMNA (0.56) | LMNAALOX15SMN1; SMN2ALDH1A1FFAR1 | |
| SCHEMBL339492 | 0.89 | ALOX15 (0.81) | LMNAALOX15SMN1; SMN2ALDH1A1FFAR1 | |
| SCHEMBL9323967 | 0.88 | ALDH1A1 (0.59) | LMNAALOX15SMN1; SMN2ALDH1A1FFAR1 | |
| SCHEMBL7874508 | 0.85 | ALOX15 (0.58) | LMNAALOX15SMN1; SMN2ALDH1A1FFAR1 | |
| SCHEMBL10428819 | 0.83 | FFAR1 (0.72) | LMNAALDH1A1FFAR1GAAMEN1 | |
| SCHEMBL25623896 | 0.83 | MAPT (0.53) | LMNASMN1; SMN2ALDH1A1FFAR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2024105168-A1 | NOVEL COMBINATIONS USEFUL FOR THE TREATMENTS OF ALS | INFLECTIS BIOSCIENCE (FR) | 2024-05-23 | — | — | WO | claimed |
| EP-4076419-A1 | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED DISORDERS | Amylyx Pharmaceuticals Inc. (US) | 2022-10-26 | — | — | EP | claimed |
| CN-114929211-A | Compositions of bile acid and phenylbutyric acid compounds | 艾米利克斯制药公司 | 2022-08-19 | — | — | CN | claimed |
| CN-114929209-A | Treatment of amyotrophic lateral sclerosis | 艾米利克斯制药公司 | 2022-08-19 | — | — | CN | claimed |
| WO-2021126870-A1 | COMPOSITIONS OF BILE ACIDS AND PHENYLBUTYRATE COMPOUNDS | Amylyx Pharmaceuticals Inc. (US) | 2021-06-24 | — | — | WO | claimed |
| WO-2021126320-A1 | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | Amylyx Pharmaceuticals Inc. (US) | 2021-06-24 | — | — | WO | claimed |
| CN-112480141-A | Pyranocoumarin derivative and preparation method and application thereof | 吉林大学珠海学院 | 2021-03-12 | — | — | CN | claimed |
| EP-3750531-A1 | COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF | Amylyx Pharmaceuticals Inc. (US) | 2020-12-16 | — | — | EP | claimed |
| US-20200230156-A1 | COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF | Amylyx Pharmaceuticals Inc. | 2020-07-23 | — | — | US | claimed |
| EP-0661932-A4 | SPECIFIC EATABLE TASTE MODIFIERS. | BIORESEARCH INC (US) | 1996-06-05 | — | — | EP | claimed |
| EP-0661932-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1995-07-12 | — | — | EP | claimed |
| WO-1993010677-A1 | SPECIFIC EATABLE TASTE MODIFIERS | BIORESEARCH, INC. (US) | 1993-06-10 | — | — | WO | claimed |
| EP-0485587-A4 | INGESTIBLES CONTAINING SUBSTANTIALLY TASTELESS SWEETNESS INHIBITORS AS BITTER TASTE REDUCERS OR SUBSTANTIALLY TASTELESS BITTER INHIBITORS AS SWEET TASTE REDUCERS | — | 1992-12-02 | — | — | EP | claimed |
| EP-0485587-A1 | INGESTIBLES CONTAINING SUBSTANTIALLY TASTELESS SWEETNESS INHIBITORS AS BITTER TASTE REDUCERS OR SUBSTANTIALLY TASTELESS BITTER INHIBITORS AS SWEET TASTE REDUCERS. | BIORESEARCH INC (US) | 1992-05-20 | — | — | EP | claimed |
| WO-1991018523-A1 | INGESTIBLES CONTAINING SUBSTANTIALLY TASTELESS SWEETNESS INHIBITORS AS BITTER TASTE REDUCERS OR SUBSTANTIALLY TASTELESS BITTER INHIBITORS AS SWEET TASTE REDUCERS | BIORESEARCH, INC. (US) | 1991-12-12 | — | — | WO | claimed |
| EP-0159864-B1 | METHOD OF MODIFYING TASTE | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1989-07-19 | — | — | EP | claimed |
| EP-0159864-A2 | Method of modifying taste | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1985-10-30 | — | — | EP | claimed |
| EP-0021177-B1 | MAYTANSINOIDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1984-02-08 | — | — | EP | claimed |
| US-4366228-A | 3-KETOCOUMARIN DERIVATIVES AS PHOTOSENSITIZERS; ALPHA-PHENYLOXYALKYLENECARBOXYLIC ACIDS AS ACTIVATORS; HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1982-12-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200230156-A1 | COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF | HSPA9, CYP27A1, TUFM | LMNA 1066/4885ALOX15 532/4885SMN1; SMN2 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.